Voice of the psychonauts: Coping, life purpose, and spirituality in psychedelic drug users

Journal of Psychoactive Drugs

Volumn 43, Issue 3, 2011, Pages 188-198

  Móró, Levente ^a   Simon, Katalin ^b   Bárd, Imre ^c   Rácz, József ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

Coping skills; Psychedelics; Quality of life; Self assessment; Spirituality

Indexed keywords

PSYCHEDELIC AGENT;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO LIFE; CONTROLLED STUDY; COPING BEHAVIOR; DRUG ABUSE; FEMALE; HUMAN; LIFE EVENT; LIFE PURPOSE; MAJOR CLINICAL STUDY; MALE; ONLINE SYSTEM; PROBLEM SOLVING; QUESTIONNAIRE; RATING SCALE; RELIGION; SELF CONCEPT; ADAPTIVE BEHAVIOR; DRUG EFFECT; DRUG SELF ADMINISTRATION; INTERNET; MIDDLE AGED; QUALITY OF LIFE; SELF EVALUATION;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; FEMALE; HALLUCINOGENS; HUMANS; INTERNET; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SELF ADMINISTRATION; SELF-ASSESSMENT; SPIRITUALITY; YOUNG ADULT;

EID: 84856375303     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2011.605661     Document Type: Article

References (61)

1. Aleman, A. & Larøi, F. 2008. Hallucinations: The Science of Idiosyncratic Perception. Washington, DC: American Psychological Association.
2. Allport, G.W. & Ross, M.J. 1967. Personal religious orientation and prejudice. Journal of Personality and Social Psychology 5 (4):432-43.
3. Antonovsky, A. 1961. The Salutogenic Model as a theory to guide health promotion. Health Promotion International 11(1):11-18.
4. Asaad, G. & Shapiro, B. 1986. Hallucinations: Theoretical and clinical overview. American Journal of Psychiatry 143:1088-97.
5. Baker, J.R. 2005. Psychedelic sacraments. Journal of Psychoactive Drugs 37 (2): 179-87.
6. Baker, J.R. 1994. Consciousness alteration as a problem-solving device: The psychedelic pathway. In: C. Rätsch & J. Baker (Eds.) Yearbook for Ethnomedicine and the Study of Consciousness. Berlin: VWB.
7. Benson, P.L. 1992. Religion and substance use. In: J.F. Schumaker (Ed.) Religion and Mental Health. New York: Oxford University Press.
8. Blätter, A. 1993. [Der erlernte Rausch. Die Funktionen des Cannabiskonsums auf Jamaika und in Deutschland]. In: C. Rätsch & J. Baker (Eds.) Yearbook for Ethnomedicine and the Study of Consciousness. Berlin: VWB.
9. Crumbaugh, J.C. & Maholick, L.T. 1964. An experimental study in existentialism: The psychometric approach to Frankl's concept of noogenic neurosis. Journal of Clinical Psychology 20: 200-07.
10. Demetrovics, Z. & Kardos, E. 2001. [Absztinens és aktív opiátfüggõk értékrendje, élettel való elégedettsége, személyes törekvései és megküzdési stratégiái]. Addictologia Hungarica 9 (3): 164-77.
11. Dobkin de Rios, M. 1971. Ayahuasca-the healing vine. International Journal of Social Psychiatry 17: 256-69.
12. Donahue, M. & Benson, P.L. 1995. Religion and the well-being of adolescents. Journal of Social Issues 51 (2):145-60.
13. Engel, G.L. 1977. The need for a new medical model: A challenge for biomedicine. Science 196 (4286): 129-36.
14. Erowid. 2010. Erowid Experience Vaults. Available at Erowid. org.
15. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 2008. Annual Report 2008: The State of the Drugs Problem in Europe. Luxembourg: Office for Official Publications of the European Communities.
16. Faillace, L.A. & Szara, S. 1968. Hallucinogenic drugs: Influence ofmental set and setting. Diseases of the Nervous System 29:124-26.
17. Farthing, G.W. 1992. The Psychology of Consciousness. Englewood Cliffs, NJ: Prentice-Hall.
18. Francis, L.J. 1997. The impact of personality and religion on attitudes towards substance use among 13-15 year olds. Drug and Alcohol Dependence 44: 95-103.
19. Frankl, V.E. 1963. Man's Search for Meaning: An Introduction to Logotherapy. New York: Washington Square Press.
20. Frecska, E. 2007. Therapeutic guidelines: Dangers and contra-indications in therapeutic applications of hallucinogens. In: M. Winkelman & T. Roberts (Eds.) Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments. Westport, CT: Praeger.
21. Garety, P.A.; Kuipers, E.; Fowler, D.; Freeman, D. & Bebbington, P.E. 2001. A cognitive model of the positive symptoms of psychosis. Psychological Medicine 31:189-95.
22. Gorsuch, R.L. 1995. Religious aspects of substance abuse and recovery. Journal of Social Issues 51(2):65-83.
23. Griffiths, R.; Richards, W.; Johnson, M.; McCann, U. & Jesse, R. 2008. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology 22 (6): 621-32.
24. Guzmán, G. 2008. Hallucinogenic mushrooms in Mexico: An overview. Economic Botany 62 (3): 404-12.
25. Halpern, J.H. & Sewell, R.A. 2005. Hallucinogenic botanicals of America: A growing need for focused drug education and research. Life Sciences 78: 519-26.
26. Hibell, B.; Guttormsson, U.; Ahlströ, S.; Balakireva, O.; Bjarnason, T.; Kokkevi, A. & Kraus, L. 2007. The 2007 ESPAD Report: Substance Use Among Students in 35 European Countries. Stockholm: ESPAD.
27. Hodge, D.R. 2003. The Intrinsic Spirituality Scale: A New six-item instrument for assessing the salience of spirituality. Journal of Social Service Research 30 (1): 41-61.
28. Hofmann, A. 1980. LSD-My Problem Child. New York: McGraw-Hill.
29. Huxley, A.L. 1954. The Doors of Perception. New York: Harper.
30. James, W. 1902/1994. The Varieties of Religious Experience: A Study in Human Nature. New York: Modern Library.
31. Johnson, M.W.; Richards, W.A. & Griffiths, R.R. 2008. Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacology 22: 603-20.
32. Jünger, E. 1970. [Psychonauten. Annäherungen: Drogen und Rausch]. Stuttgart: Ernst Klett.
33. Konkoly-Thege, B. & Martos, T. 2006. [Az életcél kérdõív magyar változatának jellemzõi]. Mentálhigiéné és Pszichoszomatika 7 (3): 153-69.
34. Kraus, L.; Augustin, R.; Frischer, M.; Kümmler, P.; Uhl, A. & Wiessing, L. 2002. Estimating prevalence of problem drug use at national level in countries of the European Union and Norway. Addiction 98: 471-85.
35. Lerner, M. & Lyvers, M. 2006. Values and beliefs of psychedelic drug users: A cross-cultural study. Journal of Psychoactive Drugs 38 (2): 143-47.
36. Lilly, J.C. 1972. The Centre of the Cyclone: An Autobiography of Inner Space. New York: The Julian Press Inc.
37. Maslow, A. 1971. The Farther Reaches of Human Nature. New York: Viking.
38. Maslow, A. 1943. A theory of human motivation. Psychological Review 50: 370-96.
39. Nahm, K.D. & Pribram, K.H. 1998. Heinrich Klüver: May 25, 1897-February 8, 1979. Biographical Memoirs 73: 288-305.
40. Nichols, D.E. 2004. Hallucinogens. Pharmacology & Therapeutics 101: 131-81.
41. Nicholson, T.; Higgins, W.; Turner, P.; James, S.; Stickle, F. & Pruitt, T. 1994. The relation between meaning in life and the occurrence of drug abuse: A retrospective study. Psychology of Addictive Behaviors 8 (1): 24-28.
42. Noblejas de la Flor, M.A. 1997. Meaning levels and drug-abuse therapy: An empirical study. International Forum for Logotherapy 20 (1): 46-52.
43. Nutt, D.; King, L.A.; Saulsbury, W. & Blakemore, C. 2007. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 369: 1047-53.
44. Oláh, A. 2005. Anxiety, Coping and Flow. Empirical Studies in Interactional Perspective. Budapest: Trefort Kiadó.
45. Passie, T.; Halpern, J.H.; Stichtenoth, D.O.; Emrich, H.M. & Hintzen, A. 2008. The pharmacology of lysergic acid diethylamide: A review. CNS Neuroscience & Therapeutics 14: 295-314.
46. Passie, T.; Seifert, J.; Schneider, U. & Emrich, H.M. 2002. The pharmacology of psilocybin. Addiction Biology 7: 357-64.
47. Prepeliczay, S. 2002. Sociocultural and psychological aspects of contemporary LSD use in Germany. Journal of Drug Issues 32 (2): 431-58.
48. Rahman, T. 2001. Mental health and purpose in life of drug addicts in Bangladesh. International Forum for Logotherapy 24 (2): 83-87.
49. Reips, U.D. 2002. Standards for Internet-based experimenting. Experimental Psychology 49 (4): 243-56.
50. Reneau, J.; Nicholson, T.; White, J.B. & Duncan, D. 2000. The general well-being of recreational drug users: A survey on the WWW. International Journal of Drug Policy 11 (5): 315-23.
51. Roberts, T.B. (Ed.) 2001. Psychoactive Sacramentals: Essays on Entheogens and Religion. San Francisco: Council on Spiritual Practices.
52. Ruck, C.A.; Bigwood, J.; Staples, D.; Ott, J. & Wasson, R.G. 1979. Entheogens. Journal of Psychedelic Drugs 11 (1-2): 145-46.
53. Sessa, B. 2008. Is it time to revisit the role of psychedelic drugs in enhancing human creativity? Journal of Psychopharmacology 22 (8): 821-27.
54. Shanon, B. 2003. Hallucinations. Journal of Consciousness Studies 10 (2): 3-31.
55. Stewart, O.C. 1987. Peyote Religion: A History. Tulsa, OK: University of Oklahoma Press.
56. Strassman, R.J. 1984. Adverse reactions to psychedelic drugs. A review of the literature. Journal of Nervous and Mental Disease 172: 577-95.
57. Tart, C.T. 1975. States of Consciousness. New York: E.P. Dutton & Co.
58. Tombor, I.; Paksi, B.; Urban, R.; Kun, B.; Arnold, P.; Rozsa, S. & Demetrovics, Z. 2010. [Epidemiology of smoking in Hungary-a representative national study]. Orvosi Hetilap 151 (9): 330-37.
59. United Nations Office on Drugs and Crime (UNODC). 2006. World Drug Report 2006, Vol. 1: Analysis. Vienna: UNODC.
60. Winkelman, M. 1995. Psychointegrator plants: Their roles in human culture, consciousness and health. In: M. Winkelman & W. Andritsky (Eds.) Yearbook of Cross-Cultural Medicine and Psychotherapy. Berlin: VWB.
61. Zinberg, N.E. 1984. Drug, Set, and Setting: The Basis for Controlled Intoxicant Use. New Haven, CT: Yale University Press.